PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study.

Federica MigliettaValentina CarraroOttavia AmatoGaia GriguoloMichele BottossoGiada MunariGiovanni ZarrilliMarcello Lo MeleCaterina BarbieriAngelo Paolo Dei TosValentina GuarneriMaria Vittoria DieciAngelo Paolo Dei Tos

Published in: Journal of clinical pathology (2023)

and mTOR-dependent pathways in shaping chemoresistance and endocrine resistance in high-risk HR+/HER2- early/locally advanced BC patients.

Keyphrases

neoadjuvant chemotherapy
locally advanced
rectal cancer
cell proliferation
end stage renal disease
squamous cell carcinoma
sentinel lymph node
lymph node
radiation therapy
chronic kidney disease
newly diagnosed
phase ii study
peritoneal dialysis
patient reported outcomes
pi k akt
early stage
signaling pathway